WHO released the recommended composition of influenza virus vaccines for use in the 2021 southern hemisphere influenza season. They are:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus;
  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

It is recommended that the influenza B virus component of trivalent vaccines for use in the 2021 southern hemisphere influenza season be a B/Washington/02/2019-like (B/Victoria lineage) virus.

At Immune Tech, we provide the following 2021 seasonal flu HA proteins —

IT-003-00117ΔTMp
IT-003-00117p
IT-003-00118p
IT-003-00439ΔTMp
IT-003-00439p
IT-003-00440ΔTMp
IT-003-00440p
IT-003-B22ΔTMp
IT-003-B22p
IT-003-B11ΔTMp
IT-003-B11p